Dogwood Therapeutics, Inc.
DWTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $11 | $3 | $43 |
| - Cash | $15 | $3 | $7 | $14 |
| + Debt | $16 | $0 | $0 | $0 |
| Enterprise Value | $3 | $7 | -$4 | $29 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12 | -$5 | -$12 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$5 | -$12 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -12.52 | -7.05 | -27.66 | -47.9 |
| % Growth | -77.6% | 74.5% | 42.3% | – |
| Operating Cash Flow | -$9 | -$5 | -$11 | -$16 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$9 | -$5 | -$11 | -$16 |